Application of the syva emit and abbott tdx amphetamine immunoassays to the detection of 3, 4-methylenedioxymethamphetamine (mdma) and 3, 4-methylenedioxyethamphetamine (mdea) in urine

Journal of Analytical Toxicology

Volumn 14, Issue 3, 1990, Pages 149-153

  Kunsman, G W ^a   Manno, J E ^a   Cockerham, K R ^a   Manno, B R ^a  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE;

ARTICLE; HUMAN; HUMAN CELL; IMMUNOASSAY; METHODOLOGY; PRIORITY JOURNAL; SPECTROMETRY; URINALYSIS;

3,4-METHYLENEDIOXYAMPHETAMINE; AMPHETAMINES; CHEMISTRY, ANALYTICAL; CROSS REACTIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; FALSE NEGATIVE REACTIONS; FLUORESCENCE POLARIZATION; HUMAN; IMMUNOENZYME TECHNIQUES; MASS FRAGMENTOGRAPHY; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; REPRODUCIBILITY OF RESULTS;

EID: 0025294315     PISSN: 01464760     EISSN: 19452403     Source Type: Journal    
DOI: 10.1093/jat/14.3.149     Document Type: Article

References (17)

1. U. Braun, A.T. Shulgin, and G. Braun. Centrally active A/-sub- stltuted analogs of 3, 4-methylenedioxyphenylisopropylamine (3, 4-methylenedioxyamphetamine). J. Pharm. Sci. 69(2): 192–95 (1980).
2. Alltech-Applied Science. “Ecstasy”. The Drug Chromatographer 3(2): 1–3 (Summer 1986).
3. C.C. Clark. The identification of methoxy-A/-methylamphetamines. J. Forens. Sci. 29: 1056–71 (1984).
4. B.A. O’Brien, J.M. Bonicamp, and D.W. Jones. Differentiation of amphetamine and its major hallucinogenic derivatives using thin- layer chromatography. J. Anal. Toxicol. 6: 143–47 (1982).
5. G.P. Dowling, E.T. McDonough III, and R.O. Bost. “Eve” and “Ecstasy”. J. Am. Med. Assoc. 257(12): 1615–17 (1987).
6. B. Eisner. Ecstasy: The MDMA story (Part 1). High Times. Aug. 88; 32–35, 73.
7. B. Eisner. Ecstasy: The MDMA story (Part 2). High Times. Sep. 88: 64–65, 71, 75, 77.
8. B. Eisner. Ecstasy: The MDMA story (Part 3). High Times. Oct. 88: 64–66.
9. R.M. Baum. New variety of street drugs poses growing problem. C&EN. September 9, 1985: 7–16.
10. R.O. Roberts. MDA, MDMA, and MDEA. Toxi-Lab News. 6(3): 1–2 (Fall 1987).
11. J.M. Ramos Jr., R.L. Fitzgerald, and A. Poklis. MDMA and MDA cross reactivity observed with Abbott TDx amphetamine/meth- amphetamine reagents. Clin. Chem. 34(5): 991 (1988).
12. W. Ruangyuttikarn and D.E. Moody. Comparison of three commercial amphetamine immunoassays for detection of metham- phetamine, methylenedioxyamphetamine, and methylenedioxy- ethylamphetamine. J. Anal. Toxicol. 12: 229–33 (1988).
13. J.E. Manno, B.R. Manno, and G.G. Pintado. Adaptation of EMIT drug abuse urine assays for use with a centrifugal analzyer. J. Anal. Toxicol. 3: 115–18 (1979).
14. Abbott Laboratories. TDx system assays: amphetamine/meth- amphetamine. Abbott Laboratories Diagnostics Division, 12/1/87 (rev.).
15. R.L. Foltz. Personal Communication. Northwest Toxicology, Inc. Salt Lake City, UT. Feb. 1, 1988.
16. K.V. Verebey, J. Alrazi, and J.H. Jaffe. The complications of ‘ecstasy’ (MDMA). J. Am. Med. Assoc. 259(11): 1649–50 (1988).
17. C. Brown and J. Osterloh. Multiple severe complications from recreational ingestion of MDMA (‘ecstasy’). J. Am. Med. Assoc. 258(6): 780–81 (1987).